Mackenzie Financial Corp Penumbra Inc Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$271.54 - $344.06 $72,229 - $91,519	-266 Reduced 30.65%	602 $207,000
Q1 2023 Apr 24, 2023	BUY	$220.43 - $278.69 $191,333 - $241,902	868 New	868 $241,000
Q1 2022 May 13, 2022	SELL	$187.51 - $283.98 $268,326 - $406,375	-1,431 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $340,692 - $412,128	1,431 New	1,431 $411,000
Q3 2021 Nov 08, 2021	SELL	$250.72 - $291.24 $188,541 - $219,012	-752 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$235.0 - $310.7 $176,720 - $233,646	752 New	752 $206,000

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.